Ryan D Howard

Array ( [id] => 13942483 [patent_doc_number] => 10206986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Annexin II variant compositions and methods [patent_app_type] => utility [patent_app_number] => 15/036115 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 9020 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11061969 [patent_doc_number] => 20160258930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/035749 [patent_app_country] => US [patent_app_date] => 2014-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27488 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298849 [patent_doc_number] => 20150183849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFE' [patent_app_type] => utility [patent_app_number] => 14/536001 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23246 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053180 [patent_doc_number] => 20160250142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB' [patent_app_type] => utility [patent_app_number] => 15/033190 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14244 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901081 [patent_doc_number] => 20150056281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta' [patent_app_type] => utility [patent_app_number] => 14/527199 [patent_app_country] => US [patent_app_date] => 2014-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19444 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10389790 [patent_doc_number] => 20150274797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'Antibody Fusion Proteins with a Modified FcRn Binding Site' [patent_app_type] => utility [patent_app_number] => 14/525910 [patent_app_country] => US [patent_app_date] => 2014-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12574 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14525910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11074265 [patent_doc_number] => 20160271229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS C VIRUS INFECTIOUS DISEASE' [patent_app_type] => utility [patent_app_number] => 15/032717 [patent_app_country] => US [patent_app_date] => 2014-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10033 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15032717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12100288 [patent_doc_number] => 09857379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Methods for treatment of cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 14/523694 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 29484 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14523694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374425 [patent_doc_number] => 20150259431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/521388 [patent_app_country] => US [patent_app_date] => 2014-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 90500 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10045232 [patent_doc_number] => 09085619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Anti-TNF antibody formulations' [patent_app_type] => utility [patent_app_number] => 14/506576 [patent_app_country] => US [patent_app_date] => 2014-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 68662 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839779 [patent_doc_number] => 20150031859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'USE OF NEW RECOMBINANT INTERFERONS WITH ALTERED SPATIAL CONFIGURATION AND THREE-DIMENSIONAL STRUCTURE' [patent_app_type] => utility [patent_app_number] => 14/498052 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 55601 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14485173 [patent_doc_number] => 10329354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Modulation of efferocytosis pathways for treatment of atherosclerotic disease [patent_app_type] => utility [patent_app_number] => 14/916517 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19959 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11002495 [patent_doc_number] => 20160199445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES' [patent_app_type] => utility [patent_app_number] => 14/914442 [patent_app_country] => US [patent_app_date] => 2014-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15647 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10939969 [patent_doc_number] => 20140342990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'MASPIN-BASED TREATMENT AND PREVENTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/445772 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11585 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14445772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933055 [patent_doc_number] => 20140336076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA' [patent_app_type] => utility [patent_app_number] => 14/444779 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7380 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10814058 [patent_doc_number] => 20160160219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'COMPOSITION CONTAINING PPAR-gamma NEDDYLATION INHIBITOR FOR INHIBITING ADIPOCYTE DIFFERENTIATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/905298 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 10634 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040202 [patent_doc_number] => 20160237156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/903489 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 87539 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857333 [patent_doc_number] => 20150037348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING' [patent_app_type] => utility [patent_app_number] => 14/328439 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 70496 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12790705 [patent_doc_number] => 20180155404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => Fusokines Involving Cytokines with Strongly Reduced Receptor Binding Affinities [patent_app_type] => utility [patent_app_number] => 14/905343 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031425 [patent_doc_number] => 09072725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Method for treating psoriasis' [patent_app_type] => utility [patent_app_number] => 14/321144 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14568 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321144 [rel_patent_id] =>[rel_patent_doc_number] =>)